Obecabtagene Autoleucel
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Obecabtagene Autoleucel, covering 2026-02-25 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia [Phase 2]